237690.KQ KOE
ST Pharm Co.,Ltd.
1W: +2.2%
1M: -9.4%
3M: -29.1%
YTD: -38.8%
1Y: +4.5%
3Y: +29.4%
5Y: -15.2%
₩93,300.00 ($69.04)
-2300.00 (-2.41%)
Weekly Expected Move ±6.1%
₩81872
₩87586
₩93300
₩99014
₩104728
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Balance Sheet Trends
Total Assets
$788.4B
+9.2% ▲
5Y CAGR: +12.1%
Total Liabilities
$192.8B
-11.9% ▼
5Y CAGR: +5.3%
Shareholders Equity
$593.4B
+17.9% ▲
5Y CAGR: +15.0%
Cash & Investments
$91.0B
-24.8% ▼
5Y CAGR: -8.3%
Total Debt
$78.7B
-33.4% ▼
5Y CAGR: -9.1%
Net Debt
$48.2B
-12.0% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $39.2B | $50.2B | $50.1B | $63.4B | $30.5B |
| Short-Term Investments | $54.0B | $0 | $40.0B | $57.5B | $60.4B |
| Cash & ST Investments | $93.2B | $50.2B | $90.1B | $120.9B | $91.0B |
| Net Receivables | $64.4B | $97.9B | $122.6B | $69.8B | $101.5B |
| Inventory | $80.8B | $107.6B | $120.7B | $127.0B | $169.5B |
| Other Current Assets | $3.6B | $4.3B | $0 | $3.8B | $7.3B |
| Total Current Assets | $247.7B | $267.6B | $348.4B | $333.7B | $379.3B |
| Property, Plant & Equip. | $210.2B | $257.9B | $280.1B | $338.7B | $359.3B |
| Goodwill & Intangibles | $12.6B | $12.5B | $13.5B | $16.5B | $17.0B |
| Long-Term Investments | $13.3B | $11.5B | $17.7B | -$46.3B | $8.1B |
| Other Non-Current Assets | $2.6B | $8.4B | $22.8B | $75.5B | $8.9B |
| Total Non-Current Assets | $257.6B | $309.3B | $334.8B | $391.8B | $409.1B |
| Total Assets | $505.2B | $570.7B | $675.4B | $721.9B | $788.4B |
| — Liabilities — | |||||
| Accounts Payable | $12.9B | $18.1B | $17.7B | $10.6B | $11.8B |
| Short-Term Debt | $15.0B | $114.1B | $29.2B | $72.2B | $77.8B |
| Deferred Revenue | $30.0B | $18.7B | $0 | $0 | $5.8B |
| Other Current Liabilities | -$15.8B | $555M | $17.1B | $41.9B | $50.2B |
| Total Current Liabilities | $52.6B | $179.2B | $83.7B | $133.3B | $165.3B |
| Long-Term Debt | $91.5B | $16.7B | $159.7B | $43.3B | $0 |
| Other Non-Current Liab. | $4.3B | $4.2B | $19.2B | $15.9B | $2.3B |
| Total Non-Current Liabilities | $120.0B | $54.1B | $204.8B | $85.6B | $27.5B |
| Total Liabilities | $178.3B | $229.5B | $288.5B | $218.9B | $192.8B |
| — Equity — | |||||
| Common Stock | $9.4B | $9.4B | $9.4B | $10.1B | $10.4B |
| Retained Earnings | $111.9B | $122.3B | $135.7B | $159.4B | $197.7B |
| Accumulated OCI | $17.3B | $21.6B | $13.5B | $18.0B | $45.7B |
| Total Stockholders Equity | $323.0B | $337.6B | $384.6B | $503.1B | $593.4B |
| Total Liabilities & Equity | $505.2B | $576.8B | $673.1B | $721.9B | $788.4B |
| — Key Metrics — | |||||
| Total Debt | $107.5B | $134.5B | $192.1B | $118.1B | $78.7B |
| Net Debt | $68.3B | $84.3B | $142.0B | $54.7B | $48.2B |
| Total Investments | $67.3B | $11.5B | $57.7B | $11.3B | $68.6B |